Matthias is an INSERM researcher at Imagine Institute in Paris, dedicated to the research and treatment of genetic disorders. He has worked on a variety of EB research projects and since 2010 he has continued to develop therapeutic approaches for RDEB, the pathophysiology of EB and to improve molecular diagnoses of genetic skin disorders in the Prof. Hovnanian’s lab. His pre-clinical work paved the way for the development of the EBGRAFT clinical trial.